Skip to main content
Signal8

You Angie

SEC insider (Form 3/4/5 filer). CIK 0001647664. Director at Attovia Therapeutics, Inc. (ATTO) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 4, 2026. Located in SAN CARLOS, CA.

Companies You Angie has filed insider reports for

  • Attovia Therapeutics, Inc. (ATTO): Director
  • Oric Pharmaceuticals, Inc. (ORIC): Director
You Angie profile photo

You Angie

CIK: 0001647664

Transaction Breakdown

Open Market Buys (P)2 (40.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Attovia Therapeutics, Inc. logo
ATTO

Attovia Therapeutics, Inc.

Director
Oric Pharmaceuticals, Inc. logo
ORIC

Oric Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Attovia Therapeutics, Inc. logo
    ATTO

    Attovia Therapeutics, Inc.

    Aug 4, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    27K shares-
  • Oric Pharmaceuticals, Inc. logo
    ORIC

    Oric Pharmaceuticals, Inc.

    Jan 2, 2026
    Award

    Stock Option (right to buy)

    Direct
    40K shares-
  • Oric Pharmaceuticals, Inc. logo
    ORIC

    Oric Pharmaceuticals, Inc.

    Jun 23, 2025
    Purchase
    Direct
    1.4K shares at avg. $9.43$13K
  • Oric Pharmaceuticals, Inc. logo
    ORIC

    Oric Pharmaceuticals, Inc.

    Jun 20, 2025
    Purchase
    Direct
    26.6K shares at avg. $9.39$250K
  • Oric Pharmaceuticals, Inc. logo
    ORIC

    Oric Pharmaceuticals, Inc.

    Jan 2, 2025
    Award

    Stock Option (right to buy)

    Direct
    35K shares-

1-5 of 5